Figure 9 is a column diagram depicting absolute rates of the most common adverse effect after drugs -dry mouth. The data came from pooled with random effects analyses from randomized controlled clinical trials. The vertical axis presents the percentage of subjects with dry mouth. The black columns present rates after drugs. The grey columns present rates after placebo. Rates of dry mouth were 34.1% after oxybutynin vs. 14.6% after placebo; 27.4% after fesoterodine vs. 7% after placebo; 22.6% after propiverine vs. 6.2% after placebo; 22% after darifenacin vs. 5.6% after placebo; 21.4% after solifenacin vs.4.5% after placebo; 18.4% after tolterodine vs.6.7% after placebo; and 15.1% after trospium vs. 4.5% after placebo. The figures demonstrates that the rates of dry mouth were the highest after oxybutynin compared to other drugs.

Figure 9Dry mouth rates (%) with drugs vs. placebo (pooled results from RCTs)

Vertical axis = percentage of subjects with dry mouth with treatment

Horizontal axis = treatments with drug or placebo

From: Results

Cover of Nonsurgical Treatments for Urinary Incontinence in Adult Women: Diagnosis and Comparative Effectiveness
Nonsurgical Treatments for Urinary Incontinence in Adult Women: Diagnosis and Comparative Effectiveness [Internet].
Comparative Effectiveness Reviews, No. 36.
Shamliyan T, Wyman J, Kane RL.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.